Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price traded down 13% during mid-day trading on Monday . The company traded as low as GBX 1.70 ($0.02) and last traded at GBX 1.70 ($0.02). 80,437 shares were traded during mid-day trading, a decline of 95% from the average session volume of 1,541,478 shares. The stock had previously closed at GBX 1.96 ($0.02).
Cizzle Biotechnology Trading Down 1.5 %
The company has a market cap of £7.59 million, a P/E ratio of -2,686.30 and a beta of 0.38. The stock’s 50 day moving average is GBX 1.81 and its 200-day moving average is GBX 1.85.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- NYSE Stocks Give Investors a Variety of Quality Options
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- How to Buy Cheap Stocks Step by Step
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Stock Market Sectors: What Are They and How Many Are There?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
